Effect of SAMITAL® in the treatment of chemotherapy-induced mucositis in adult oncohematological patients

Future Oncology

Volumn 9, Issue 11, 2013, Pages 1727-1732

  Bertoglio, Juan Carlos ^a   Calderón, Susana ^a   Lesina, Blaz ^a   Pilleux, Lilian ^a   Morazzoni, Paolo ^b   Riva, Antonella ^b   Bombardelli, Ezio ^b   Ronchi, Massimo ^b   Cabri, Walter ^b   Petrangolini, Giovanna ^b  

^a Medical School   (Chile)

^b INDENA S P A   (Italy)

Author keywords

hematological; mucositis; oncology; SAMITAL ; solid tumor; supportive care

Indexed keywords

ANTINEOPLASTIC AGENT; HERBACEOUS AGENT; SAMITAL; UNCLASSIFIED DRUG;

ADULT; AGED; ALLERGY; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPHAGIA; EROSION; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MALE; MUCOSA INFLAMMATION; PAIN; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; MUCOSITIS; PLANT EXTRACTS; YOUNG ADULT;

EID: 84887304966     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.13.164     Document Type: Article

References (36)

1. Lichtman MA. Battling the hematological malignancies: the 200 years' war. Oncologist 13(2), 126-138 (2008).
2. Sant M, Allemani C, Tereanu C et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 116(19), 3724-3734 (2010).
3. Keefe DM, Brealey J, Goland GJ, Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47(5), 632-637 (2000).
4. Keefe DM, Gibson RJ, Hauer-Jensen M. Gastrointestinal mucositis. Semin. Oncol. Nurs. 20(1), 38-47 (2004).
5. Keefe DM, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE. Effect of high-dose chemotherapy on intestinal permeability in humans. Clin. Sci. 92(4), 385-389 (1997).
6. Stringer AM, Gibson RJ, Bowen JM, Logan RM, Yeoh AS, Keefe DM. Chemotherapy-induced mucositis: the role of gastrointestinal microfora and mucins in the luminal environment. J. Support. Oncol. 5(6), 259-267 (2007).
7. Yeoh AS, Bowen JM, Gibson RJ, Keefe DM. Nuclear factor kappaB (NFkappaB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. Int. J. Radiat. Oncol. Biol. Phys. 63(5), 1295-1303 (2005).
8. Sonis ST. Pathobiology of mucositis. Semin. Oncol. Nurs. 20(1), 11-15 (2004).
9. Keefe DM, Schubert MM, Elting LS et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109(5), 820-831 (2007).
10. Sharma R, Tobin P, Clarke SJ. Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea. Lancet Oncol. 6(2), 93-102 (2005).
11. Sonis ST. A biological approach to mucositis. J. Support. Oncol. 2(1), 21-32; discussion 35-26 (2004).
12. Sonis S T, Elting LS, Keefe D et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(Suppl. 9), S1995-S2025 (2004).
13. Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent. Clin. North Am. 52(1), 61-77 (2008).
14. Scardina GA, Pisano T, Messina P. Oral mucositis. review of literature. NY State Dent. J. 76(1), 34-38 (2010).
15. Migliorati C, Hewson I, Lalla RV et al. Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support. Care Cancer 21(1), 333-341 (2013).
16. Peterson DE, Bensadoun RJ, Roila F et al. Management of oral and gastrointestinal mucositis: ESMO clinical practice guidelines. Ann. Oncol. 21(Suppl. 5), v261-v265 (2010).
17. Raber-Durlacher JE, von Bultzingslowen I, Logan RM et al. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support. Care Cancer 21(1), 343-355 (2013).
18. Cheah KY, Howarth GS, Yazbeck R et al. Grape seed extract protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis. Cancer Biol. Ther. 8(4), 382-390 (2009).
19. Loo WT, Jin LJ, Chow LW, Cheung MN, Wang M. Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients. Expert Opin. Investig. Drugs 19(Suppl. 1), S91-S100 (2010).
20. Wright TH, Yazbeck R, Lymn KA et al. The herbal extract, Iberogast, improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositis. Cancer Biol. Ther. 8(10), 923-929 (2009).
21. Slatnar A, Jakopic J, Stampar F, Veberic R, Jamnik P. The effect of bioactive compounds on in vitro and in vivo antioxidant activity of different berry juices. PLoS One 7(10), e47880 (2012).
22. Bornsek SM, Ziberna L, Polak T et al. Bilberry and blueberry anthocyanins act as powerful intracellular antioxidants in mammalian cells. Food Chem. 134(4), 1878-1884 (2012).
23. Niu X, Fan T, Li W, Xing W, Huang H. The anti-infammatory effects of sanguinarine and its modulation of infammatory mediators from peritoneal macrophages. Eur. J. Pharmacol. 689(1-3), 262-269 (2012).
24. Barnes J, Anderson LA, Gibbons S, Phillipson JD. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 57(8), 929-954 (2005).
25. US FDA. US Food and Drug Administration Guidance for Industry: Botanical Drug Products. US FDA, MD, USA (2004).
26. ® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind Phase II study. Support. Care Cancer 21(3), 827-834 (2013).
27. ®. Future Oncol. 8(11), 1481-1486 (2012).
28. Bossi P, Bergamini C, Mirabile A et al. SAMITAL® in prophylaxis of chemo-radiotherapy (CT-RT) induced mucositis in head and neck squamocellular cancer (HNSCC) patients (PTS): results of a prospective monoinstitutional Phase II trial. Ann. Oncol. 21(Suppl. 8), S328 (2010).
29. ® granules for oral suspension to treat chemo-radiotherapy (CT/RT) induced oral mucositis in head/neck neoplasms. Support. Care Cancer 19(Suppl. 2), S264 (2011).
30. ®: a new challenge for the treatment of oral mucositis induced by chemoradiotherapy. Support. Care Cancer 19(Suppl. 2), S251 (2011)
31. WHO. Handbook For Reporting Results of Cancer Treatment. WHO, Geneva, Switzerland, 15-22 (1979).
32. Peterson DE, Bensadoun RJ, Roila F on behalf of the ESMO Guidelines Working Group. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann. Oncol. (Suppl. 6), S78-S84 (2011).
33. Ling IS, Larsson B. Individualized pharmacological treatment of oral mucositis pain in patients with head and neck cancer receiving radiotherapy. Support. Care Cancer 19(9), 1343-1350 (2011).
34. Niu X, Fan T, Li W, Huang H, Zhang Y, Xing W. Protective effect of sanguinarine against acetic acid-induced ulcerative colitis in mice. Toxicol. Appl. Pharmacol. 267(3), 256-265 (2013).
35. Piberger H, Oehme A, Hofmann C et al. Bilberries and their anthocyanins ameliorate experimental colitis. Mol. Nutr. Food Res. 55(11), 1724-1729 (2011).
36. Morazzoni P, Cristoni A, Di Pierro F et al. In vitro and in vivo immune stimulating effects of a new standardized Echinacea angustifolia root extract (Polinacea). Fitoterapia 76(5), 401-411 (2005).